중합효소 연쇄 반응(PCR) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Polymerase Chain Reaction Market size is expected to reach USD 17.92 Billion in 2034 from USD 7.39 Billion (2025) growing at a CAGR of 10.34% during 2026-2034.

The Global Polymerase Chain Reaction market has witnessed substantial growth due to rising demand for molecular diagnostics and genetic research. PCR technology enables rapid amplification of DNA, making it essential in disease detection and forensic analysis. Increasing prevalence of infectious diseases and genetic disorders has boosted adoption. Expanding biotechnology research and pharmaceutical development further strengthen market growth.

Key growth drivers include advancements in real-time and digital PCR technologies. Laboratories rely on PCR for accurate and fast diagnostic results. Growing investment in precision medicine and personalized healthcare also supports expansion. Additionally, automation and improved reagent formulations enhance testing efficiency.

Future prospects remain promising as molecular diagnostics become more accessible worldwide. Integration with portable and point-of-care devices will broaden applications. Expanding research in genomics and oncology will further stimulate demand. The PCR market is expected to sustain steady growth driven by innovation and healthcare advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• PCR Instruments
• Standard PCR Systems
• RT PCR Systems
• Digital PCR Systems
• PCR Reagents
• PCR Consumables

By End User

• Pharmaceutical & Biotechnology Industries
• Clinical Diagnostics Labs & Hospitals
• Academic & Research Organizations

COMPANIES PROFILED

• BioRad Laboratories Inc, Stilla, Standard BioTools, Siemens Healthineers, BioMerieux SA, Danaher Corporation, Thermo Fisher Scientific Inc, Qiagen NV, Becton Dickinson Company BD, Abbott Laboratories, Agilent Technologies, F HoffmannLa Roche Ltd, Microsynth AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. PCR Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Standard PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. RT PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Digital PCR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. PCR Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. PCR Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical & Biotechnology Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinical Diagnostics Labs & Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POLYMERASE CHAIN REACTION MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL POLYMERASE CHAIN REACTION INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bio-Rad Laboratories Inc
  • 8.2.2 Stilla
  • 8.2.3 Standard BioTools
  • 8.2.4 Siemens Healthineers
  • 8.2.5 BioMerieux S.A
  • 8.2.6 Danaher Corporation
  • 8.2.7 Thermo Fisher Scientific Inc
  • 8.2.8 Qiagen N.V
  • 8.2.9 Becton Dickinson & Company (BD)
  • 8.2.10 Abbott Laboratories
  • 8.2.11 Agilent Technologies
  • 8.2.12 F. Hoffmann-La Roche Ltd
  • 8.2.13 Microsynth AG